Indraprastha Medical Corporation Limited (BOM:532150)
India · Delayed Price · Currency is INR 392.15
+20.50 (5.52%)
At close: May 27, 2026
BOM:532150 Revenue
In the fiscal year ending March 31, 2026, Indraprastha Medical Corporation had annual revenue of 15.11B INR with 11.42% growth. Indraprastha Medical Corporation had revenue of 3.72B in the quarter ending March 31, 2026, with 11.50% growth.
Revenue
15.11B
Revenue Growth
+11.42%
P/S Ratio
2.42
Revenue / Employee
4.88M
Employees
3,035
Market Cap
35.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 15.11B | 1.55B | 11.42% |
| Mar 31, 2025 | 13.56B | 1.12B | 8.97% |
| Mar 31, 2024 | 12.45B | 1.46B | 13.29% |
| Mar 31, 2023 | 10.99B | 2.11B | 23.70% |
| Mar 31, 2022 | 8.88B | 2.75B | 44.80% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Steel Strips Wheels | 49.42B |
| West Coast Paper Mills | 40.96B |
| Sanghvi Movers | 11.00B |
| Hind Rectifiers | 9.99B |
| Gufic Biosciences | 8.97B |
| Bliss GVS Pharma | 8.68B |
| BN Agrochem | 8.26B |
| Marathon Nextgen Realty | 5.31B |
Indraprastha Medical Corporation News
- 8 months ago - Top gainers today: Indraprastha Medical up 12.94%, Shaily Engineering up 10.06%, RHI Magnesita India up 8.27%, DOMS Industries up 5.56%, GMM Pfaudler up 5.26% as of 11 AM - Business Upturn